While it is often stated that psychiatric co-morbidity in PWE is under-recognized and under-
treated, little research has directly examined this assertion. The aims of this study were to …

Objective The objective of this study was to assess for independent association of anxiety
symptoms with epilepsy localization and other epilepsy-related and demographic factors in …

Objective This study aimed to explore the quality of life (QoL) of adult patients with epilepsy
(PwE) in Australia and its relationship with comorbidities and adverse events (AEs) from …

Abstract Objective Anxiety disorders (ADs) are common in patients with epilepsy (PWE). The
aim of this study was to estimate the prevalence of specific ADs in outpatients with epilepsy …

Objective Although the use of antiepileptic drugs (AEDs) is routine, 30–40% of patients with
epilepsy (PWEs) experience drug resistance. Thus, early identification of AED resistance will …

Aim Anxiety can have a profound influence on the health‐related quality of life of people with
epilepsy and caregivers. The study aimed to assess the prevalence and associated factors …

Although there has been increasing recognition of psychiatric comorbidity in epilepsy, most
research and attention in this area has focused on depression. However, comorbid anxiety …

Epilepsy surgery is an effective treatment option for drug-resistant focal epilepsy patients
with associated structural brain lesions. However, little epidemiological data are available …

Epilepsy, a severe neurological disorder impacting approximately 50 million individuals
worldwide, is associated with a high prevalence of mental health issues. However, existing …

Refractory epilepsy often has deleterious effects on an individual's health and quality of life.
Early identification of patients whose seizures are refractory to antiepileptic drugs is …